安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- VCU researchers are developing a long-acting medication for . . .
In hope of providing more treatment options for opioid use disorder, the VCU research team reworked nor-levo-alpha-acetylmethadol, a metabolite of a previous FDA-approved opiate dependence medication, into a new formulation that could be used to help patients with opioid addiction
- Buprenorphine Lowers Opioid OD Risk, But Only If Taken As . . .
THURSDAY, Nov 20, 2025 — The opioid addiction medication buprenorphine can dramatically lower risk of overdose among teenagers and young adults — but only if taken long-term, a new study says
- Medical Breakthrough Offers Hope To Those Fighting Addiction
A new drug that helps people with a substance dependency detoxification —in five days—from opioids and alcohol without painful withdrawal symptoms recently completed a proof-of-concept
- FDA Approves New Buprenorphine Treatment Option for Opioid . . .
The U S Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)
- FDA OKs painkiller designed to end opioids addiction and . . .
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin
- FDA approves painkiller designed to . . . - Associated Press News
U S officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids
- Its easier now to treat opioid addiction with medication—but . . .
People with opioid addiction often need to take buprenorphine daily for months to years to overcome addiction to the opioid they are trying to quit—whether it's heroin, prescription painkillers such as hydrocodone and oxycodone, or synthetic opioids like fentanyl
- FDA Approves New Drug for Opioid Use Disorder: Brixadi®
The FDA's approval of Brixadi® marks a significant milestone in the battle against opioid addiction This medication offers healthcare professionals and patients a new option for the treatment of opioid use disorder, with its extended-release formulation providing convenience and improved medication adherence
|
|
|